Emerald Health Signs Supply Agreement with Stenocare

Emerald Health Therapeutics (TSXV: EMH) is Stenocare’s new supplier of choice following the fallout earlier this year with Canntrust Holdings (TSX: TRST) (NYSE:CTST). Under the newly signed agreement, Emerald Health will become a supplier for Stenocare for both Denmark and other international markets.

Within the release issued this morning, it was revealed that Emerald Health has been working with Stenocare in the background since September to pre-qualify Emerald’s production methods and products. Stenocare had terminated its previous agreement with Canntrust during that same month, as a result of the firm losing its production licenses for illegally growing cannabis in unlicensed rooms at their Pelham, Ontario facility. It was also previously discovered that such illegally grown product had been shipped to Stenocare in Denmark, resulting in Stenocare being required to issue a recall on its products.

Under the new agreement Emerald will progress towards having multiple oil products approved for international export. Stenocare and Emerald will now progress towards receiving approval from the Danish Medicines Agency for approval for Emerald’s products in the Danish Medical Cannabis Pilot Programme. No timeline was given for an estimated approval date.

As Emerald ramps up production at its two recently fully-licensed production facilities, we look forward to fulfilling our commitment to STENOCARE and helping them to serve Danish patients.

Riaz Bandali, CEO of Emerald

Anticipated export quantities were not provided within today’s news release.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

Emerald Health Therapeutics closed yesterdays session at $0.72 on the TSX Venture.


Information for this briefing was found via Sedar and Emerald Health Therapeutics. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Epic Gold Outlines 150,700 Indicated Ounces at 2.26 G/T in Updated Benoist Resource

Related News

Bonify Holdings Reinstated: Is There Now Hope For Canntrust Holdings?

There might be hope for Canntrust Holdings (TSX: TRST) (NYSE: CTST) and its shareholders after...

Wednesday, October 23, 2019, 06:03:04 PM

Canntrust Holdings Sees Health Canada Reinstate Cannabis Licenses At Fenwick Facility

Canntrust Holdings (OTC: CTST) appears to, somehow, be on the mend. The company announced this...

Friday, May 29, 2020, 08:02:15 AM

Canntrust Obtains Creditor Protection, Anticipates TSX, NYSE Delisting

Canntrust Holdings (TSX: TRST) (NYSE: CTST) this morning announced that it has entered into creditor...

Tuesday, March 31, 2020, 11:05:39 AM

OSC Withdraws Charges Against CannTrust Officials Following Inaccurate Witness Testimony

The Ontario Securities Commission withdrew its case against three CannTrust officials initially charged with securities...

Wednesday, December 14, 2022, 01:41:36 PM

CannTrust Fires CEO Peter Aceto, Chairman Eric Paul Resigns

This evening news broke via Jameson Berkow on Twitter Canntrust has terminated CEO Peter Aceto...

Thursday, July 25, 2019, 07:29:47 PM